Moderna (MRNA) — insider trading
Health Care · NASDAQ
Moderna (MRNA) has 36 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 36 (latest 2026-07-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | Hoge Stephen | Officer (President) | Option exercise / conversion (derivative) | 16,110 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Hoge Stephen | Officer (President) | Option exercise / conversion (derivative) | 37,226 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Hoge Stephen | Officer (President) | Open-market sale | 53,336 | $67.60 | $3.61M | Form 4 |
| 2026-07-15 | Hoge Stephen | Officer (President) | Option exercise / conversion | 16,110 | $19.15 | $308.5K | Form 4 |
| 2026-07-15 | Hoge Stephen | Officer (President) | Option exercise / conversion | 37,226 | $19.15 | $712.9K | Form 4 |
| 2026-07-08 | McDonnell Michael R. | Director | Grant / award / vesting (derivative) | 5,733 | $0.00 | $0 | Form 4 |
| 2026-07-08 | McDonnell Michael R. | Director | Grant / award / vesting (derivative) | 1,618 | $0.00 | $0 | Form 4 |
| 2026-07-08 | McDonnell Michael R. | Director | Grant / award / vesting (derivative) | 7,415 | $0.00 | $0 | Form 4 |
| 2026-07-05 | Banque Soria Ester | Officer (Chief Commercial Officer) | Grant / award / vesting (derivative) | 38,364 | $0.00 | $0 | Form 4 |
| 2026-07-05 | Banque Soria Ester | Officer (Chief Commercial Officer) | Grant / award / vesting (derivative) | 18,658 | $0.00 | $0 | Form 4 |
| 2026-07-02 | Mock James M | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 1,452 | $0.00 | $0 | Form 4 |
| 2026-07-02 | Mock James M | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 703 | $72.50 | $51.0K | Form 4 |
| 2026-07-02 | Mock James M | Officer (Chief Financial Officer) | Option exercise / conversion | 1,452 | — | — | Form 4 |
| 2026-06-15 | Hoge Stephen | Officer (President) | Option exercise / conversion (derivative) | 16,110 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Hoge Stephen | Officer (President) | Option exercise / conversion (derivative) | 37,226 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Hoge Stephen | Officer (President) | Open-market sale | 53,336 | $51.37 | $2.74M | Form 4 |
| 2026-06-15 | Hoge Stephen | Officer (President) | Option exercise / conversion | 16,110 | $19.15 | $308.5K | Form 4 |
| 2026-06-15 | Hoge Stephen | Officer (President) | Option exercise / conversion | 37,226 | $19.15 | $712.9K | Form 4 |
| 2026-06-05 | Mock James M | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 11,798 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Mock James M | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 5,705 | $51.59 | $294.3K | Form 4 |
| 2026-06-05 | Mock James M | Officer (Chief Financial Officer) | Option exercise / conversion | 11,798 | — | — | Form 4 |
| 2026-06-05 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 11,798 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 5,705 | $51.59 | $294.3K | Form 4 |
| 2026-06-05 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Option exercise / conversion | 11,798 | — | — | Form 4 |
| 2026-06-04 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 3,471 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Open-market sale | 3,471 | $50.00 | $173.6K | Form 4 |
| 2026-06-04 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Option exercise / conversion | 3,471 | $30.96 | $107.5K | Form 4 |
| 2026-06-01 | Hoge Stephen | Officer (President) | Option exercise / conversion (derivative) | 9,282 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Hoge Stephen | Officer (President) | Shares withheld for taxes / exercise cost | 4,488 | $47.19 | $211.8K | Form 4 |
| 2026-06-01 | Hoge Stephen | Officer (President) | Option exercise / conversion | 9,282 | — | — | Form 4 |
| 2026-06-01 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 2,165 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 1,047 | $47.19 | $49.4K | Form 4 |
| 2026-06-01 | Klinger Shannon Thyme | Officer (Chief Legal Officer) | Option exercise / conversion | 2,165 | — | — | Form 4 |
| 2026-06-01 | Mock James M | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 2,475 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Mock James M | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,197 | $47.19 | $56.5K | Form 4 |
| 2026-06-01 | Mock James M | Officer (Chief Financial Officer) | Option exercise / conversion | 2,475 | — | — | Form 4 |
Ask the chat about MRNA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Moderna (MRNA).
Last updated 2026-07-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.